Intracellular glutathione heterogeneity in L1210 murine leukemia sublines made resistant to dna-interacting anti-neoplastic agents
- 28 May 1993
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 54 (3) , 435-442
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.Proceedings of the National Academy of Sciences, 1992
- Contribution of glutathione and glutathione‐dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell linesInternational Journal of Cancer, 1991
- The relationship between nuclear glutathione levels and resistance to melphalan in human ovarian tumour cellsBiochemical Pharmacology, 1991
- Flow cytometric monitoring of glutathione content and anthracycline retention in tumor cellsCytometry, 1991
- Flow cytometric measurement of glutathione content of human cancer biopsiesBritish Journal of Cancer, 1990
- Morpholinyl anthracyclines: Option for reversal of anthracycline resistanceEuropean Journal of Cancer and Clinical Oncology, 1990
- The multidrug resistance phenotypeBritish Journal of Cancer, 1988
- Characterization of the inhibition of glutathione reductase and the recovery of enzyme activity in exponentially growing murine leukemia (11210) cells treated with 1,3-bis(2-chloroethyl)-1-nitrosoureaBiochemical Pharmacology, 1988
- [51] Assays for differentiation of glutathione S-Transferases1981
- Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissuesAnalytical Biochemistry, 1969